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Summary 
Metastatic epidural spinal cord compression (MESCC) is a medical emergency complicating the course of 
5-10% of patients with cancer [1]. When diagnosis and treatment is early with the patient ambulatory progno- 
sis for continued ambulation is good [2]. If the patient is nonambulatory or paraplegic, prognosis for meaning- 
ful recovery of motor and bladder function is markedly decreased. In the last decade, significant advances in 
the understanding, management and treatment of metastatic epidural spinal cord compression have occurred. 
Recent pathophysiological and pharmacological animals studies have afforded insights into disease mecha- 
nisms [3-9]. The audit of standard methods of investigation and magnetic resonance imaging have resulted in 
revision of guidelines for patient evaluation [10-17]. Finally, new surgical philosophies and technical advances 
have generated interest and controversy [18-25]. With improved clinical awareness, new imaging modalities 
will help us diagnose epidural spinal cord compression earlier and institute appropriate treatment. 
Introduction 
Metastatic epidural spinal cord compression 
(MESCC) will be defined as compression of the spi- 
nal cord or cauda equina nerve roots from a lesion 
outside the spinal dura. It is the initial manifestation 
of malignancy in half of cases diagnosed in a general 
hospital [26], but less than 8% diagnosed in cancer 
centers [2]. The most common tumors causing epi- 
dural compression are breast, lung, prostate, lym- 
phoma, sarcoma, and kidney, accounting for over 
70% of cases [2, 26-30]. 
In this paper, we review and summarize current 
concepts regarding the management of MESCC 
based on recent diagnostic advances and technical 
surgical developments. The review is based on our 
experience and critical appraisal of recent articles 
or seminal papers on metastatic epidural spinal 
cord compression. We discuss the pros and cons of 
diagnostic and treatment strategies to reduce the 
degree of uncertainty in selecting the appropriate 
modality for each clinical situation. 
Pathogenesis and pathophysiology 
The epidural space is a true space which lies be- 
tween spinal cord dura and the bony spinal canal. It 
contains fat, connective tissue and a rich paraver- 
tebral venous plexus which drains the vertebrae 
and intervertebral spaces. The most common mech- 
anism of metastatic epidural spinal cord compres- 
sion is thought to be by hematogenous arterial 
spread to bone marrow, which results in vertebral 
body collapse and formation of an anterior epidural 
mass. A second mechanism is spread by direct in- 
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vasion of tumor through the intervertebral forami- 
na from a paravertebral source. This occurs in 75 % 
of patients wiht epidural spinal cord compression 
due to lymphoma, and 15% of patients with meta- 
static epidural spinal cord compression from other 
solid tumors [31-33]. 
Although unproven, another probable mecha- 
nism of metastatic epidural spinal cord compres- 
sion is by retrograde venous spread from the pri- 
mary site via Batson's paravertebral plexus. If tu- 
mor cells are injected into the femoral vein, when 
intra-abdominal pressure is normal, metastases de- 
velop in the lungs, and when intra-abdominal pres- 
sure is increased, epidural metastases without ver- 
tebral involvement are produced [34]. In humans, it 
is rare to find metastatic epidural spinal cord com- 
pression without bony involvement or direct spread 
through the bony foramina. 
Animal models have been used to demonstrate 
morphological features of cord damage and subse- 
quent recovery [35, 36]. Following 3 hours of cord 
compression in cats, selective demyelination with- 
out axonal disruption evolves over the subsequent 
21 hours and continues for 1 week. Most demyel- 
inated fibres show evidence of remyelination by 
one month [36]. If compression is produced slowly 
over a 48 hour period and maintained for 7 days, it is 
still possible to get recovery of paralysis, suggesting 
that demyelination is a more important factor than 
cord ischemia. With more prolonged compression 
there was cord ischemia and irreversible neurolog- 
ical changes. If tumor cells are injected into the epi- 
dural space in rats, one of the earliest features of 
metastatic epidural spinal cord compression is 
breakdown of the blood-spinal cord barrier with 
vasogenic edema [37]. Administration of steroids 
decreases the vasogenic edema and produces objec- 
tive improvement in weakness [38]. 
At autopsy, in humans with metastatic epidural 
spinal cord compression, there is vascular conges- 
tion, hemorrhage and edema at the site of cord com- 
pression suggesting that venous occlusion is an im- 
portant factor in the pathogenesis of cord damage. 
Topographical localization 
Eighty-four to ninty-four percent of patients with 
MESCC have an abnormal plain x-ray at the time of 
presentation [26, 27]. Over 30% of patients will 
have x-ray evidence of multiple sites of vertebral in- 
volvement and if plain x-rays, tomography and sur- 
gical findings are combined, as many as 86% may 
have more than one vertebra involved [27, 29]. Mul- 
tiple vertebral involvement is particularly common 
in breast and prostatic carcinoma. Metastatic epi- 
dural spinal cord compression most commonly oc- 
curs at the site of vertebral involvement on plain x- 
ray, especially where there is evidence of vertebral 
collapse. The primary compression of the spinal 
cord from metastatic deposits occurs in the thoracic 
region of approximately 70% of patients, the lum- 
bosacral spine in 20% and the cervical spine in 10% 
of patients [2, 26, 32]. Multiple sites of metastatic 
epidural spinal cord compression occur in 17-30% 
of all patients [39]. This is particularly common in 
breast cancer and is uncommon in lung cancer [26]. 
In a review of 600 cases of spinal cord or nerve 
root compression, vertebral metastases occurred in 
563 patients [27]. The vertebral body was involved 
in 45% of these patients, the posterior arch in 41% 
and the entire vertebra in the remaining 14% of pa- 
tients. Epidural lesions without vertebral involve- 
ment occurred in 30 patients and intradural lesions 
in 7 patients. The location within the vertebra of 
metastatic involvement is important for the surgical 
treatment of epidural spinal cord compression but 
is not a good indicator of the primary site of neo- 
plasm [33]. Epidural metastases usually do not in- 
vade the dura. Posterior extradural tumor is easily 
accessible by laminectomy, but anterior extradural 
disease may require an anterior cervical, transtho- 
racic or transabdominal approach. 
History and examination 
The median age at diagnosis of metastatic epidural 
spinal cord compression has varied from 53 to 63 
years with sex differences reflecting the primary 
neoplasm e.g. breast and prostate [2, 26-30]. 
Back pain is the initial complaint in up to 96% of 
patients with epidural spinal cord compression [2]. 
Pain may precede neurological symptoms by days 
to 3 or more years [1]. It is very unusual for patients 
with metastatic epidural spinal cord compression to 
present without pain [28], but cord compression 
from lung or renal metastases and lymphoma do so 
more frequently [1, 26]. The median duration of 
pain before development of neurological signs has 
varied from 7 to 23 weeks [2, 26]. Duration of pain is 
probably related to tumor growth rate, being short- 
est for highly malignant tumors such as lung and 
kidney and longest for more typically less malig- 
nant tumors such as breast and prostate carcinoma. 
The majority of patients have local pain, secondary 
to stretching of the pain sensitive cortical bone and 
periosteum. Local pain is usually constant, relent- 
lessly progressive and exacerbated by coughing, 
sneezing, straining or exercise [1, 2]. The worsening 
of pain on recumbency is the most distinctive fea- 
ture of the pain of metastatic epidural spinal cord 
compression and differentiates it from disc disease 
[1, 2]. Radicular pain is present in 90% of patients 
with lumbosacral, 79% of cervical and 55% of pa- 
tients with thoracic metastatic epidural spinal cord 
compression [2]. It is frequently bilateral in the tho- 
racic area and unilateral or bilateral in the lumbo- 
sacral and cervical areas. Radicular pain is an im- 
portant localizing sign [2]. 
Weakness is present in about 80% of patients 
with metastatic epidural spinal cord compression at 
presentation [2]. Fifty percent of patients are ambu- 
latory, 35 % are paraparetic and 15 % are paraplegic 
at the time of diagnosis [2]. Once weakness is pre- 
sent, progression is often rapid and urgent investi- 
gation and treatment is crucial [2, 26]. Thirty per- 
cent of patients with weakness become paraplegic 
within one week [1]. Rate of progression of weak- 
ness is dependent on the tumor growth rate [1]. 
Weakness is usually bilateral and symmetrical 
(87%) [2]. The degree of weakness and ability to 
ambulate at the time of diagnosis are important 
clinical predictors of outcome [2, 26-29]. 
Bladder and bowel symptoms are also frequently 
present at the time of diagnosis (57%) and can take 
the form of frequency, urinary retention or inconti- 
nence [2]. Autonomic disturbance is a bad prognos- 
tic sign as it implies bilateral cord or root damage 
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and is usually associated with moderate to severe 
weakness [2]. Objective sensory disturbance is 
found in 78% of patients at the time of diagnosis [2]. 
The severity of sensory loss almost always mirror 
the severity of motor weakness [1, 40]. 
Care should be taken to examine lymph nodes, 
breasts, lungs, kidneys and perform a rectal exam 
[40]. Limited straight leg raising usually points to an 
epidural or intradural extramedullary lesion caus- 
ing root compression, while segmental pain and sac- 
ral sparing suggests intramedullary disease [40]. 
Spinal cord, conus medullaris, cauda equina, or pe- 
ripheral nerve lesions can produce a flaccid areflex- 
ic paralysis [1, 40]. Concurrent cerebral symptoms 
or signs favor performance of MRI where there is 
no risk of neurologic deterioration [41]. If there are 
two spinal levels involved clinically or on an x-ray, 
then both sites must be clearly imaged [2]. 
Differential diagnosis 
If clinical outcome is to be improved, it is important 
to identify patients with metastatic epidural spinal 
cord compression early in their illness and start 
treatment as soon as possible [26, 28, 41]. Approxi- 
mately 50% of adult patients presenting with an 
acute transverse myelopathy will be diagnosed as 
having metastatic epidural spinal cord compression 
[42]. In 47 % of patients who develop metastatic epi- 
dural spinal cord compression, it is the initial pre- 
sentation of their malignancy, and of these almost 
half will have lung carcinoma identified [2, 27]. 
However, less than 50% of patients with malig- 
nancy, considered clinically to have metastatic epi- 
dural spinal cord compression, will have this diag- 
nosis confirmed by myelography [43]. Myelography 
in cancer patients with back pain and myelopathy is 
normal in 23% of patients, and with back pain and 
radiculopathy is normal in 37% of patients [44]. 
A history of previous radiation therapy, trauma, 
vascular or disc disease or infection is important. 
Patients taking anticoagulants have an increased 
risk of subdural hematoma [45]. Chemotherapy in- 
creases the risk of infections and hemorrhage [46, 
47]. Patients receiving chronic steroids may develop 
cord compression from epidural fat [48]. 
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The differentiation between epidural abscess and 
metastasis is often difficult [40]. Epidural abscess is 
more frequently posteriorly situated and will often 
cover multiple vertebral body segments [49]. If 
there is vertebral collapse due to an infective cause, 
the disc space is frequently destroyed while meta- 
static vertebral disease usually spares the disc space 
[49, 50]. Epidural abscess may be associated with 
increased systemic white blood cell count, fever or 
cerebrospinal fluid pleocytosis, but as the dura is an 
effective barrier, the cerebrospinal fluid may be 
normal. Blood cultures yield the correct organism 
more often [49, 50]. 
Arteriovenous malformations can produce mye- 
lopathy as a result of direct pressure or following 
hemorrhage. In the majority of cases the arteriove- 
nous malformation is at the thoraco-lumbar junc- 
tion, either extradural or intradural, while in ap- 
proximately 10% the arteriovenous malformation 
arises from the anterior spinal artery and is intrame- 
dullary in the cervical cord [40]. They may be identi- 
fied by their 'snake like' appearance on myelogra- 
phy or by demonstrating flow voids or character- 
istic signal changes of hemorrhage using magnetic 
resonance imaging [51]. 
Carcinomatous meningitis occurs in approxi- 
mately 5 % of cancer patients at autopsy [52, 53]. In- 
tradural extramedullary or intramedullary metasta- 
ses have frequencies of less than 4 % that of epidural 
spinal cord compression [54]. Noncompressive 
causes of neural involvement should also be consid- 
ered. Vascular damage to the spinal cord may cause 
myelopathy as a result of direct pressure or com- 
pression of major feeding radicular arteries as they 
enter through the intervertebral foramina. Myelo- 
pathy secondary to radiation, intrathecal metho- 
trexate chemotherapy, infectious diseases, coagulo- 
pathies and paraneoplastic syndromes may occur in 
patients with cancer [10, 40]. 
Between 30-45% of patients who are nonambula- 
tory with antigravity proximal leg function will re- 
gain ambulation, where as only 5% of patients who 
have no antigravity proximal function will walk 
again [2]. (Helweg-Larson S, Sorenson PS, Hanson 
SW, personal communication). The radiobiology of 
the tumor also plays an important role in response. 
In one study, 75 % of patients with radiosensitive tu- 
mors, who were nonambulatory but could raise 
their legs off the bed became ambulant after radio- 
therapy, but only 34% of comparable patients with 
radioresistant tumors became ambulant after ra- 
diotherapy [2]. After treatment, the probability of 
ambulant patients surviving one year is 0.73 and the 
probability of non ambulant patients surviving one 
year is 0.09 [55]. In selected series of paraplegic pa- 
tients with anterior epidural spinal cord compres- 
sion treated with anterior decompression and ra- 
diotherapy, between 50-90 % of patients had an im- 
provement in motor function [24, 56]. 
Histology of the tumor may be more important in 
determining prognosis than the type of treatment 
[1]. Myeloma, lymphoma and breast carcinoma 
have almost a 80% initial response rate and 75% of 
patients with breast carcinoma who are still alive at 
a year remain ambulatory [2, 28]. Only 25% of pa- 
tients with lung or renal carcinoma and melanoma 
respond to any treatment modality [2]. 
Rapid onset and quick progression are bad prog- 
nostic variables [57]. Patients with a pre-operative 
symptom duration greater than 2 months have bet- 
ter postoperative recovery of function than those 
with shorter histories [58]. The duration of paraple- 
gia before starting treatment is also important. It 
has been traditionally taught that when paraplegia 
is present for greater than 24 hours before initiation 
of treatment the changes of recovery are slight [59, 
60], although recent reports question this doctrine 
[611. 
Clinical prognosis 
The severity of weakness at presentation is the most 
significant prognostic variable for recovery of func- 
tion. Eighty percent of patients who were ambula- 
tory at presentation, remain so after treatment [2]. 
Investigations 
Plain x-rays are an essential, highly predictive, in- 
expensive, quick investigation that should be ob- 
tained if myelography or magnetic resonance imag- 
ing scanning is pending. Between 85-94% of pa- 
tients with metastatic epidural spinal cord compres- 
sion have an abnormal plain x-ray at the time of 
presentation [26]. If there is back pain or a localiz- 
ing sign and spinal x-ray is abnormal, the probabil- 
ity of epidural disease is 0.9, but if the x-ray is nor- 
mal, it is only 0.1 [16, 62]. Spinal x-rays have a sensi- 
tivity of 91% for predicting epidural disease and a 
specificity of 86% [62]. Bone scanning has a similar 
sensitivity but a specificity of only 53 %. Particularly 
useful radiological features for predicting epidural 
disease are; greater than 50% vertebral collapse 
(85%), and pedicular erosion (31%) [14, 62]. 
Spinal computed assisted tomography is valuable 
in investigating cancer patients with local back pain 
who have a normal exam and spinal x-rays. Two 
thirds of these patients have spinal metastases on 
computer assisted tomography scan but only 17% 
will have metastatic epidural spinal cord compres- 
sion and in these cases none will have greater than 
50% block [13]. Patients without cortical disruption 
on computer assisted tomography, rarely develop 
metastatic epidural spinal cord compression at that 
site at a later date [63]. 
Different algorithms for the investigation of pa- 
tients with cancer and back pain have resulted from 
recent clinical studies utilizing spinal x-rays, bone 
scanning and spinal computed assisted tomography 
[15,16, 62]. All advise myelography, with or without 
computed assisted tomography, if the spinal x-ray is 
abnormal (Table 1, authors algorithm). 
Magnetic resonance imaging is replacing myelog- 
raphy as the procedure of choice, although there are 
no prospective trials comparing the diagnostic yield 
of myelography, with or without spinal computer 
assisted tomography, with that or magnetic reso- 
nance imaging in patients presenting with symp- 
toms suggestive of metastatic epidural spinal cord 
compression [64, 65]. However, it is adviseable to 
get the test that is readily available, as the patient 
may deteriorate while waiting for investigation. In 
many centers this may still be myelography with or 
without computer assisted tomography. 
Magnetic resonance imaging is non-invasive, ef- 
fectively demonstrates metastatic epidural spinal 
cord compression and gives a positive image of the 
spinal cord to better diagnose intramedullary dis- 
ease [64-66]. Intradural extramedullary metastases 
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[12] are equally well diagnosed by gadolinium en- 
hanced magnetic resonance imaging or by myelog- 
raphy [64, 66]. Asymptomatic second areas of meta- 
static epidural spinal cord compression are identi- 
fied with MRI and are important for radiation plan- 
ning. Anatomical definition of vertebral and 
extraspinal disease on magnetic resonance imaging 
is helpful when planning a surgical procedure. It is 
helpful to perform sagittal magnetic resonance 
imaging 'scout scans' (Fig. 1), using the body coil, as 
they will often identify multiple vertebral deposits 
which can subsequently be studied in more detail 
using local spinal coils (Fig. 2). Magnetic resonance 
imaging has fewer risks than myelography in pa- 
tients with intracranial mass lesions or bleeding 
tendencies. Where there has been previous surgery 
or scoliosis, sagittal images are difficult to interpret. 
Patients who are claustrophobic or who have a fer- 
romagnetic implant cannot be scanned. Severe pain 
or other causes of movement artifact may limit in- 
terpretation of the scans and myelography would 
then be preferable. 
Myelography is as sensitive as magnetic reso- 
nance imaging at identifying extradural or intrad- 
ural extramedullary lesions and has the added ad- 
vantage of yielding cerebrospinal fluid which may 
help to exclude or confirm alternative diagnoses, 
e.g. carcinomatous meningitis or abscess. The addi- 
tion of spinal computer assisted tomography im- 
proves sensitivity for bony and paravertebral invol- 
vement. Clinical deterioration may occur directly 
following myelography [67, 68], however, it is diffi- 
cult to separate this from natural history of disease. 
If there is a complete block following lumbar injec- 
tion, a cervical myelogram or magnetic resonance 
imaging is necessary to visualize the upper limit of 
the block and to exclude second lesions. All pa- 
tients with suspected MESCC should have their to- 
tal spine imaged [69]. 
If the cause of epidural spinal cord compression is 
uncertain, computer assisted tomography guided 
biopsy of a paraspinal or epidural mass or percuta- 
neous needle biopsy of a collapsed vertebral body 
may be helpful [70]. 
Simple investigations such as chest radiograph, 
prostatic specific antigen, mammography, abdom- 
inal ultrasound or abdominal and chest computer 
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Fig. 1. MRI (using the body coil) showing two areas of vertebral 
involvement. One with ESCC at T8 and another asymptomatic 
L3 metastasis. 
assisted tomography scan may immediately demon- 
strate the primary malignancy in patients who pre- 
sent with metastatic epidural spinal cord compres- 
sion. 
Treatment recommendations for patients at risk 
from metastatic epidurai spinal cord compression 
In order to improve clinical outcome in the future, it 
is important to identify patients at high risk for 
metastatic epidural spinal cord compression, be- 
fore the appearance of neurological symptoms of 
signs. Patients with malignancy should be advised 
to inform their physician if they develop new back 
pain, the initial complaint in up to 96% of patients 
who go on to develop metastatic epidural spinal 
cord compression. High risk patients will include 
patients with known malignancy and recent onset 
back pain and patients who are not known to have 
malignancy, but who have new backache, worse on 
recumbency or radicular, situated in the thoracic re- 
gion or associated with spinal tenderness. These pa- 
Fig. 2. MRI (using local spinal coil) showing severe metastatic 
ESCC with collapse of C5 vertebral body and severe destruction 
of posterior elements and local invasion of C4 and C6 bodies. 
tients will require A-P and lateral plain x-rays of the 
involved areas (Table 1). Oblique x-rays are needed 
if there is radicular pain as foramina enlargement 
may be missed on standard views. If there is evi- 
dence of focal bony pathology, myelography will 
demonstrate an abnormality in approximately 60% 
of cases [44]. If the spine x-rays are normal but the 
pain is characteristic, a spinal computer assisted to- 
mographic scan is recommended [13], since plain x- 
rays have a false negative rate of up to 17% [71]. 
Spinal computer  assisted tomographic scanning will 
accurately differentiate between bony metastases 
and benign bony disease [63]. If computer  assisted 
tomography demonstrates bony metastases or a pa- 
raspinal mass, then MRI or computer assisted to- 
mography-myelography is indicated. 
Radiation therapy is the treatment of choice for 
bony metastases without metastatic epidural spinal 
cord compression, as this provides very effective 
palliation for bone pain and will prevent progres- 
sion to epidural metastases in most cases [72]. 
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Table 1. 
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(a)  MRI: Magnetic Resonance Imaging 
(d) CSF: Cerebrospinal Fluid 
(b) CT: Computed Tomography (c) RT: Radiation Therapy 
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Emergency measures 
Patients with cancer, back pain and an abnormal 
progressing neurologic examination, demonstra- 
ting myelopathy or radiculopathy, should undergo 
emergency MRI or computer assisted tomography- 
myelography, whichever is the most readily avail- 
able procedure (Table 1). Stable patients with un- 
certain neurological findings can be scanned ur- 
gently over the next twenty-four hours. Control of 
pain prior to myelography or magnetic resonance 
imaging may help to prevent movement artifact. 
High doses of steroids such as 100 mg dexametha- 
sone i.v. and 24 mg six hourly will produce pain re- 
lief in 64% of patients within 24 hours and can also 
result in significant clinical improvement [28]. High 
dose i.v. dexamethasone can cause side effects in- 
cluding vaginal burning, elevations in blood pres- 
sure and glucose intolerance and electrolyte dis- 
turbance, and caution should be used in those sus- 
pected of having an infection or gastrointestinal 
symptoms. Doses should be tapered rapidly and im- 
mediately if there is less than 80% spinal block or 
gradually after 72 hours, following treatment with 
radiotherapy or surgery. 
Patients with MESCC and abnormal neurologic 
examination with weakness should be monitored at 
frequent intervals with a neurologic exam. If pa- 
tients develop a neurologic deficit during radiation 
therapy and it is unresponsive to steroid dose in- 
crease, directed surgical approach should be con- 
sidered. If back pain is due to vertebral involvement 
with spinal instability and the patient has otherwise 
limited disease spinal stabilization should be con- 
sidered [73]. 
In experimental studies, dexamethasone can be 
identified in spinal cord within 5 minutes of i.v. in- 
jection and has a half life of approximately 4 hours. 
A dexamethasone dose response effect has been 
demonstrated in an animal model of metastatic epi- 
dural spinal cord compression [7, 38], producing de- 
creased spinal cord water content, reduced epidural 
swelling and a transient clinical improvement. A 
prospective randomized double blinded trial of sin- 
gle high dexamethasone dose (100 mg iv) compared 
with conventional initial dose (10 mg iv), both sub- 
sequently followed by 4 mg orally every 6 hours did 
not demonstrate a significant difference in ambula- 
tion, bladder function or control of pain at 24 hours 
[74]. However at 3 hours, 7% of patients treated 
with the conventional initial dose steroids deterio- 
rated and only 41% had pain relief, compared with 
no deterioration and 53% pain relief in the high ini- 
tial dose group. Based on the half life of dexametha- 
sone any effect of single high dose decadron would 
be expected to be of short duration and a more pro- 
longed course of high dose steroids may be justified. 
In a prospective randomized double blind placebo 
controlled trial in acute spinal cord injury, high dose 
bolus and then continuous methylprednisone im- 
proved neurologic motor and sensory recovery [75]. 
Patients with neoplastic spinal cord compression 
are at an increased risk of deep venous thrombosis 
and pulmonary embolus. Prophylactic subcutane- 
ous heparin, anti-embolic stockings or compression 
pumps [76], will help reduce morbidity and mortal- 
ity. In the presence of urinary retention or constipa- 
tion, intermittent or permanent catheterization 
should be considered and laxatives/suppositories 
should be initiated early in the course of admission. 
Care should be taken when nursing patients with 
paraparesis or paraplegia to prevent pressure sores. 
In patients who have previously been treated with 
maximal radiation therapy and who are unfit for 
surgery, non operative treatment with spinal braces 
can be offered. 
From 1963-1980 several selected series [30, 33, 
37] compared the results of surgical decompression 
alone versus decompression followed by radiation 
therapy and demonstrated markedly better results 
in the latter group. In 1978, a retrospective non-ran- 
domized series of 235 patients with metastatic epi- 
dural spinal cord compression concluded that radi- 
ation therapy alone is as effective as decompressive 
laminectomy and radiation therapy [2]. This study 
was instrumental in changing initial therapy for 
metastatic epidural spinal cord compression from 
surgery to radiation therapy. There has only been 
one randomized prospective comparison of lami- 
nectomy followed by radiation therapy versus radi- 
ation therapy alone [78]. This failed to reveal any 
difference between the treatment arms, however 
the sample size made it difficult to demonstrate a 
significant difference [29, 78]. Recently, a renewed 
interest in surgery has focused on a directed surgical 
approach based on the site and level of metastatic 
epidural spinal cord compression. 
Radiotherapy 
The response of epidural metastatic lesions to radi- 
ation is well documented [27, 79-81]. Lymphoma, 
seminoma, myeloma, Ewing's sarcoma and neuro- 
blastomas are very radiosensitive, breast and pros- 
tate less so, and kidney, colon, lung and melanoma 
are frequently radioresistant. 
Radiation therapy is still the generally accepted 
first line of treatment of metastatic epidural spinal 
cord compression in radiosensitive tumors. Its use 
in radioresistant tumors is more controversial. A 
large retrospective study reported that radioresis- 
tant tumors are as effectively treated with radiation 
therapy alone as with laminectomy and radiation 
therapy [2]. The optimal dose and fractionation re- 
gimen for metastatic epidural spinal cord compres- 
sion remains unknown [82]. In fact, there may be no 
generally optimal plan. Each plan constructed rep- 
resents a compromise between delivery of the high- 
est dose achievable to improve tumor control, a de- 
sire to achieve palliation as expediently as possible, 
and the intrinsic radiosensitivity of the spinal cord, 
often a regimen of 30 Gy in 10 fractions is chosen as 
the best solution [82]. 
The treatment technique depends upon the re- 
gion of spinal involvement. Cervical spine lesions 
are generally treated with opposed lateral portals 
that provide a homogenous dose distribution to the 
involved region while sparing the pharyngeal mu- 
cosa from the acute effects of radiation. Thoracic 
spine lesions are most often treated with posterior 
fields for simplicity and ease of patient setup. The 
additional dose delivered to more superficial tis- 
sues with a posterior-only beam arrangement can 
be significant especially for lower energy treatment 
units. A posterior wedged-pair arrangement mini- 
mizes this problem and also spares anteriorly situat- 
ed soft tissues. Due to the near-midline location of 
the lumbar spine, these lesions are usually treated 
with opposed anterior and posterior portals. Tradi- 
tionally, two vertebral bodies above and below the 
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myelographic block have been treated, taking into 
account other vertebral bodies with documented 
metastasis. Whether these volume recommenda- 
tions for spinal irradiation will continue in the mod- 
ern imaging era remains to be seen. The sensitivity 
of the spinal cord to radiation limits the prescribed 
amount of therapy and the spinal cord dose should 
always be calculated as well as the dose to the in- 
volved vertebral body. The incidence of permanent 
radiation injury to the spinal cord directly corre- 
lates with the total dose and fraction size [83]. Spi- 
nal cord tolerance has been considered to be be- 
tween 45-50 Gy in 180 cGy fractions, between 35- 
37.5 Gy in 250 cGy fractions and between 30-33 Gy 
in 300 cGy fractions. In primates given a total radi- 
ation dose of 52 Gy in 2.2 Gy fractions, only 0.1% 
developed myelopathy with a latent period ranging 
from 5 to 20 months [84]. The size of the radiation 
field also plays an important role and reductions in 
treatment volume allow a larger dose [85]. Radi- 
ation therapy has recently been reported to pro- 
duce a delayed recovery in ambulation (3 to 6 
months) in patients paraplegic for up to nine days. 
Recovery was more common in patients whose 
weakness had a gradual onset over weeks [61]. 
Surgery 
The role of surgery is being re-evaluated. Surgery is 
a major undertaking in patients with metastatic dis- 
ease who have limited life expectancy. Neverthe- 
less, it has been advocated to obtain diagnostic ma- 
terial, to help the rapidly deteriorating patients, to 
decompress the spinal cord and nerve roots, correct 
spinal instability, relieve pain and promote early 
mobilization. Spinal instability is a potential cause 
of cord damage and is not affected by radiation 
therapy [25]. Recently, spinal surgeons extrapolat- 
ing from traumatic spinal cord injury, and using a 
similar framework have divided the bony space into 
three columns: Anterior Column - anterior longitu- 
dinal ligament and vertebral body; Middle Column 
- posterior longitudinal ligament, posterior verte- 
bral body, pedicles; Posterior Column -facet joints, 
lamina, interspinous ligaments. Spinal instability 
occurs most often if the cortical bone in more than 
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one of three columns are involved, either by tumor 
or by previous surgery. Surgical relief of pain can be 
achieved in 68% to 85% of patients [20, 21]. 
Most old trials compared decompressive lami- 
nectomy with radiation therapy. Decompressive la- 
minectomy for metastatic epidural spinal cord com- 
pression in the presence of vertebral body collapse 
is contraindicated. It has a 25% risk of major neur- 
ological deterioration, 22% risk of spinal instability 
and only 3 % recovery of ambulation [56, 86]. The 
only indications for decompressive laminectomy 
are tissue diagnosis and removal of posteriorly sit- 
uated epidural deposits, when vertebral disease is 
absent. In a retrospective study of patients with rap- 
idly progressing weakness developing over 48 hours 
or less, radiation therapy was shown to be superior 
to posterior decompressive laminectomy in return 
of patients to ambulatory status [2]. In this same se- 
ries radiosensitive lesions did better than radiore- 
sistant lesions regardless of treatment (surgery or 
radiation) emphasizing that the type of tumor is 
prognostically more important than the type of 
therapy [2]. Paraplegic patients traditionally have 
not improved with posterior decompressive lami- 
nectomy but anterior vertebral body resection 
shows some promise in paraplegic patients [24, 25]. 
In surgically treated posterior metastatic epidural 
spinal cord compression, one-third of patients re- 
gain ambulation and continence, but the incidence 
of paraplegia increases from 8 % pre-operatively to 
26% post-operatively [23]. Problems with wound 
closure and infection, which may be increased with 
radiation therapy, produce significant morbidity. 
Longer term problems are spinal instability or non- 
fusion and worsening pain. Posterior stabilization 
may be required following decompressive laminec- 
tomy to prevent spinal instability. 
In selected patients with spinal instability, ante- 
rior decompression should be considered before ra- 
diation therapy [73]. Patients with vertebral com- 
pression with anteriorly placed epidural lesions will 
require a transthoracic, transabdominal or retrope- 
ritoneal approach for vertebral body resection. An- 
terior stabilization is usually produced using Stein- 
mann pins and methyl methacrylate or bone graft. 
Concomitant posterior stabilization may be neces- 
sary if the neural arch is also involved with tumor. 
Clinical outcome following anterior decompres- 
sion in patients with a single anteriorly situated epi- 
dural metastasis is remarkably good. Fifty-two per- 
cent of these patients, who are in good general 
health and have either failed radiation or have a ra- 
dioresistant tumor, will have an improvement in 
ambulation and a median survival of 16 months [24]. 
Operative mortality is 7% and surgical morbidity is 
11%. Transient neurological worsening occurs in 
approximately 2%. Spinal instability develops in 
5 % of patients and recompression at the initial site 
will eventually occur in 22% of patients. 
In other surgical series the vertebral body resec- 
tion, pain improved in 60 to 97% and neurologic 
function improved in 55 to 97% [19, 22, 25, 87]. 
However, in one study the post-operative mortality 
was almost 36% [22]. In a small series of thirteen 
patients who had anterior decompression after fail- 
ure of decompressive laminectomy, almost 50% de- 
teriorate and only 8 % improve [56]. Prior radiation 
therapy may also increase the morbidity and mor- 
tality of anterior decompression [25, 88]. 
Single stage synchronous anterior decompres- 
sion by a posteriolateral approach with posterior 
stabilization has been advocated in patients with 
vertebral collapse and destruction of the neural 
arch posteriorly [20, 23]. Initial results in selected 
patients are encouraging with two-thirds of non- 
ambulant patients in one series regaining the ability 
to walk [20]. This combined procedure by a post- 
eriolateral approach may reduce respiratory or ab- 
dominal complications related to anterior transtho- 
racic or transabdominal surgery. 
Chemotherapy 
Chemotherapy may have a place in treating pa- 
tients who have metastatic epidural spinal cord 
compression and have previously had radiation and 
are not surgical candidates, or those with wide- 
spread metastases [89-91]. Complete resolution of 
paraparesis following intravenous chemotherapy 
has been reported in patients with breast cancer 
who have failed radiation [92]. 
Conclusion 
Epidural  spinal cord compression is a complication 
of systemic malignancy and usually signifies dissem- 
inated disease with shortened survival. Early diag- 
nosis is crucial. The initial symptom is almost al- 
ways local back or radicular pain. If  radiculopathy 
or myelopathy is present  on neurological exam, or 
spine x-rays are abnormal,  emergent  magnetic reso- 
nance imaging or myelography/computer  assisted 
tomography  is indicated. In cancer patients with lo- 
cal back pain and normal  neurologic exam and 
spine x-rays, the probabil i ty of metastat ic epidural 
spinal cord compression is 0.1 and computer  assist- 
ed tomography or magnetic resonance imaging 
scanning is recommended.  If computer  assisted to- 
mography of the spine demonstrates  cortical dis- 
ruption, the patient  should then have M R I  or mye- 
lography. If  investigations demonstra te  a benign 
cause for backache this can be treated symptomat-  
ically. If  investigations fail to reveal a clear cause for 
backache and symptoms presist, M R I  and cerebral  
spinal fluid analysis for cytology is justified. 
Proper  emergent  management  of metastat ic epi- 
dural spinal cord compression requires the close 
and timely cooperat ion of medical oncologists, ra- 
diologists, neurologists, neurosurgeons,  or thopaed-  
ic surgeons and radiation oncologists. Steroids will 
reduce pain and may lead to temporary  neurolog- 
ical improvement .  Radiat ion therapy is equal in ef- 
fect to posterior  decompressive laminectomy in 
both radiosensitive and radioresistant tumors. 
Therefore,  radiation is the most  appropriate  and 
readily available option for the majority of patients. 
In selected cases with anterior epidural compres-  
sion and spinal instability, initial management  
should be an anterior surgical approach or synchro- 
nous vertebral  decompression with posterior  stabi- 
lization. Posterior decompressive laminectomy 
alone is contraindicated in patients with vertebral  
collapse. In patients with posterior epidural disease 
without tissue diagnosis, laminectomy with or with- 
out stabilization should be performed.  
The literature on metastat ic epidural spinal cord 
compression is notable for the lack of good rando- 
mized studies dealing with clinical aspects and ther- 
apeutic options. There  is however, a randomized 
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multi-institutional study in progress to investigate 
patients with metastatic epidural spinal cord com- 
pression who are 'surgical candidates '  to study the 
question whether  lesion directed surgery with stabi- 
lization and radiation is more  effective than radi- 
ation alone. 
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